![](https://cdn.physiciansweekly.com/wp-content/uploads/2024/08/rheumatoid-arthritis.png)
CZP Proven Effective for RA with High RF Compared to ADA
The following is a summary of “Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis,” published in the September 2024 issue of Rheumatology by Smolen et al. Researchers …